Device / Technology News

RSS

ReCor completes enrollment in PARADISE system clinical study for 'resistant' hypertension

ReCor Medical, an emerging medical device company, announced today that it has completed enrollment in the REDUCE 15-patient pilot clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.

14 May 2012

Toshiba’s Aquilion ONE CT system improves detection of acute stroke

Kaleida Health's Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.'s Aquilion ONE CT system in diagnosing acute stroke.

14 May 2012

Positive data from Piramal Healthcare’s BST-CarGel Phase III cartilage repair trial

Piramal Healthcare Bio-Orthopaedics, a division of Piramal Healthcare Limited, today announced that positive data from their pivotal (Phase III) clinical trial is being presented in 3 podium presentations as well as during an Industry Symposium at the 10th World Congress of the International Cartilage Repair Society (ICRS), May 12 to 15, in Montreal, Quebec, Canada.

14 May 2012

New clinical trial to evaluate effectiveness of ABMT for PTSD

At Ease USA, a Nebraska organization dedicated to providing confidential post-traumatic stress disorder (PTSD) care for military families, has launched a clinical trial of a promising new therapeutic intervention at Creighton University.

14 May 2012

Automated external defibrillators rarely close to locations of public cardiac arrests

More than 75 percent of cardiac arrest victims are stricken too far away from an automated external defibrillator for the lifesaving device to be obtained quickly enough to offer the best chance at saving their lives, according to new research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the annual meeting of Society for Academic Emergency Medicine.

14 May 2012

DIBH can spare hearts and lungs of breast cancer patients from radiation

Respiratory movement during radiotherapy makes it difficult to hit the right treatment target and this in turn can lead to an under-dose of radiation to the tumour, or a potentially toxic over-dose to the surrounding healthy tissue. Getting this right is a real challenge for the radiotherapist, but new techniques are helping to deliver the correct dose to the right place, the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) will hear today.

14 May 2012

Kidney transplants more frequent among NxStage home hemodialysis patients

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today commented on findings of the Chronic Disease Research Group (CDRG) study showing that patients receiving daily, or more frequent, home hemodialysis with the NxStage System One are more likely to receive a kidney transplant when compared with conventional thrice-weekly dialysis, particularly in patients not on the transplant waitlist at initiation of daily home hemodialysis.

14 May 2012

New mom receives surprise heart transplant

New mom Windy Hill, 38, of Kingsport, Tenn., was given the ultimate Mother's Day gift a little early after she was wheeled into the operating room at Vanderbilt University Hospital on April 20 to receive a mechanical pump to aid her failing heart and save her life.

14 May 2012

New EMR tool helps reduce unnecessary abdominal CT scan use among ER patients

A new electronic medical record tool that tallies patients' previous radiation exposure from CT scans helps reduce potentially unnecessary use of the tests among emergency room patients with abdominal pain, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the annual meeting of the Society for Academic Emergency Medicine.

14 May 2012

Study demonstrates accuracy of AliveCor’s iPhone-based ECG

AliveCor, the developer of a breakthrough mobile electrocardiogram (ECG) recorder, today announced results from a study that demonstrated the accuracy of the company's iPhone-based device, by comparing its Lead I to Lead I from a conventional 12-lead ECG. The study found that the iPhone-based event recorder is an accurate clinical tool for ECG assessment and could prove to be a new tool for allowing immediate recording and analysis of an ECG rhythm.

From AliveCor, Inc. 14 May 2012

CRT-D cost-effective treatment for mildly symptomatic heart failure patients

Medtronic, Inc. today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in Ambulatory Heart Failure Trial) trial demonstrating that cardiac resynchronization therapy with defibrillation (CRT-D) is a cost-effective treatment for mildly symptomatic heart failure patients.

14 May 2012

Novel heart monitoring device helps ER patients avoid unnecessary follow-up care

A study conducted at Scripps Health has found that a novel new heart monitoring device helped emergency room patients avoid unnecessary follow-up care. Scripps Health electrophysiologist Steven Higgins, MD, presented findings of the study titled, "Prevalence of Arrhythmias in Emergency Department Patients Discharged Using a Novel Ambulatory Cardiac Monitor", today at the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston.

14 May 2012

New system may help restore vision in eye diseases

Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenerative eye diseases.

14 May 2012

HIV community supports rapid OTC testing

Who's Positive, a national HIV awareness organization, today announced the results of a year-long online survey measuring support for over-the counter (OTC) HIV testing. The organization will present these results at the upcoming U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) on May 15, 2012.

11 May 2012

Killer coating destroys bacteria and fungi on contact

Better than antibiotics, it is being used in contact lenses to prevent infections and biomedical products are the next stage

11 May 2012

Accelerated partial breast irradiation does not compromise survival

Using a concentrated, highly targeted dose of radiation to the breast has equally good results as irradiating the whole area, with no adverse effects on survival and a much better cosmetic outcome, Hungarian researchers have found.

11 May 2012

Study supports catheter ablation as first-line treatment for paroxysmal atrial fibrillation

Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment.

11 May 2012

New discovery platform for antigen-specific monoclonal antibodies

Cell Signaling Technology, Inc. of Danvers, MA is pleased to announce the development of a new discovery platform for antigen-specific monoclonal antibodies.

From Cell Signaling Technology 11 May 2012

BIOTRONIK launches new Reocor external pacemaker

BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.

11 May 2012

Dyax introduces free Attack Tracker smartphone application for hereditary angioedema patients

Dyax Corp. today announced the launch of a free smartphone application for the iPhone - HAE Attack Tracker. This application allows HAE patients to keep detailed records of their disease related information, including emergency and physician contacts as well as individual attack data.

11 May 2012